Insulin reduces plasma arginase activity in type 2 diabetic patients.
about
Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-AtherosclerosisTargeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular DiseasesRole for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesisInsulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009Diagnosing impaired glucose tolerance using direct infusion mass spectrometry of blood plasma.Oxidative status imbalance in patients with metabolic syndrome: role of the myeloperoxidase/hydrogen peroxide axis.Arginase inhibition augments nitric oxide production and facilitates left ventricular systolic function in doxorubicin-induced cardiomyopathy in mice.Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase functionUpregulation of arginase activity contributes to intracellular ROS production induced by high glucose in H9c2 cellsOxidative stress biomarkers and their relationship with cytokine concentrations in overweight/obese pregnant women and their neonatesChronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic MiceArginase promotes skeletal muscle arteriolar endothelial dysfunction in diabetic ratsArginase inhibition alleviates hypertension in the metabolic syndrome.Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS.Development of novel arginase inhibitors for therapy of endothelial dysfunctionSelective up-regulation of arginase-1 in coronary arteries of diabetic patients.Uncovering metabolic pathways relevant to phenotypic traits of microbial genomes.To give or not to give? Lessons from the arginine paradox.Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?Combining citrulline with atorvastatin preserves glucose homeostasis in a murine model of diet-induced obesity.Postprandial hyperglycemia impairs vascular endothelial function in healthy men by inducing lipid peroxidation and increasing asymmetric dimethylarginine:arginine.Critical role for arginase 2 in obesity-associated pancreatic cancer.Effects of acute hyperglycaemia on cardiovascular homeostasis: does a spoonful of sugar make the flow-mediated dilatation go down?Metabolomic profiles indicate distinct physiological pathways affected by two loci with major divergent effect on Bos taurus growth and lipid deposition.Arginase activity and magnesium levels in blood of children with diabetes mellitus.Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil.Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunction.Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans.Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approachsingle nucleotide polymorphisms rs2781666 and rs2781665 confer risk of Type 2 diabetes mellitus
P2860
Q26991946-8C70356B-1EAA-4025-9EEC-849CFD531700Q28073279-EB054590-2879-4FF9-8DDA-2D1190D62DEAQ33569387-7334B3A4-3038-4481-8366-4718A57D6BFEQ33880303-36290796-431F-4C8E-A07C-CD62A4924F0DQ34155246-3E2B4731-7FFE-448A-8191-13C5239DF77EQ34438220-D773BE8F-E140-4257-A6EA-C940D7DF682BQ34730537-5BB384CF-036C-477C-A140-F6112A0935DBQ35217395-74F75BDA-8503-4CCE-86D9-0F5AE75B90B8Q35632147-634D3AA1-81F9-4455-8B4B-FE35E83827A7Q36243211-C7A2CDC6-52F9-47A4-918E-74CE1A9C290DQ36467779-87909D74-D342-4E6F-83EA-820CA79C437DQ36854784-AEA5A3C0-44E9-41EC-8BAA-32253F62D79BQ36929472-2B300AC3-584F-42DF-94CD-5B07DCE18353Q37142734-5B30A3F7-ABDC-44E6-9865-DC19FA2E869DQ37176702-2D21139F-8AB6-4B99-A65C-72C0087D8EA3Q37199274-94F25DBD-AB5E-469D-BFB7-D25A548997D9Q37213785-E4188608-807F-4E60-9A27-E606533F8607Q37882383-B32EFDA0-6878-4FB9-9F19-7849EB19AA65Q38082329-F0B5BD1D-5A4B-4A20-A5CC-42C0C26A07B1Q38297306-A52FEFB7-BFA5-4B00-B114-FDAA77566595Q39704946-B9DFEB8F-0948-4C01-B9FD-4D206E4CD6A1Q41388458-EE915BF1-6FAA-4DFA-B37D-B00F810567ABQ42089623-1F517B6E-6655-411D-95A8-32FAEF05053AQ42963654-3046654E-5301-4B6C-8A4B-F2E42CF00290Q43137426-D9FDBC66-0391-403B-8725-F8BBA4855580Q48669899-CC49BAC8-A6D8-4045-B9D1-4C22793C5826Q53099095-9450FEC5-5A67-41F1-907A-31389DD5CBEAQ53798961-6564FB2D-7E6D-4CD2-8923-F5947146FC58Q57577431-7DD68506-A32F-4ABE-8B5B-FB0A4EC02FFFQ58700252-047C0FEF-CE93-474E-9C72-65305F9DD62F
P2860
Insulin reduces plasma arginase activity in type 2 diabetic patients.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Insulin reduces plasma arginase activity in type 2 diabetic patients.
@ast
Insulin reduces plasma arginase activity in type 2 diabetic patients.
@en
type
label
Insulin reduces plasma arginase activity in type 2 diabetic patients.
@ast
Insulin reduces plasma arginase activity in type 2 diabetic patients.
@en
prefLabel
Insulin reduces plasma arginase activity in type 2 diabetic patients.
@ast
Insulin reduces plasma arginase activity in type 2 diabetic patients.
@en
P2093
P2860
P356
P1433
P1476
Insulin reduces plasma arginase activity in type 2 diabetic patients.
@en
P2093
Abigail Lara
Renliang Zhang
Sangeeta R Kashyap
Young Mi Park
P2860
P304
P356
10.2337/DC07-1198
P407
P577
2007-10-10T00:00:00Z